Guido Kroemer

369.2k total citations · 83 hit papers
1.4k papers, 235.5k citations indexed

About

Guido Kroemer is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Guido Kroemer has authored 1.4k papers receiving a total of 235.5k indexed citations (citations by other indexed papers that have themselves been cited), including 721 papers in Molecular Biology, 425 papers in Immunology and 330 papers in Oncology. Recurrent topics in Guido Kroemer's work include Autophagy in Disease and Therapy (285 papers), Cell death mechanisms and regulation (270 papers) and Immunotherapy and Immune Responses (179 papers). Guido Kroemer is often cited by papers focused on Autophagy in Disease and Therapy (285 papers), Cell death mechanisms and regulation (270 papers) and Immunotherapy and Immune Responses (179 papers). Guido Kroemer collaborates with scholars based in France, Sweden and United States. Guido Kroemer's co-authors include Lorenzo Galluzzi, Laurence Zitvogel, Beth Levine, Oliver Kepp, Naoufal Zamzami, Santos A. Susín, Daolin Tang, Carlos López-Otı́n, Douglas R. Green and Rui Kang and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Guido Kroemer

1.3k papers receiving 232.6k citations

Hit Papers

The Hallmarks of Aging 1995 2026 2005 2015 2013 2008 1999 2007 2023 2.5k 5.0k 7.5k 10.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Hallmarks of Aging
    2013 10.4k citations Carlos López-Otı́n, Guido Kroemer et al. profile →
  2. Autophagy in the Pathogenesis of Disease
    2008 5.9k citations Guido Kroemer et al. profile →
  3. Molecular characterization of mitochondrial apoptosis-inducing factor
    1999 3.3k citations Guido Kroemer et al. profile →
  4. Self-eating and self-killing: crosstalk between autophagy and apoptosis
    2007 3.0k citations Maria Chiara Maiuri, Guido Kroemer et al. profile →
  5. Hallmarks of aging: An expanding universe
    2023 3.0k citations Carlos López-Otı́n, Guido Kroemer et al. profile →
  6. Mitochondrial Membrane Permeabilization in Cell Death
    2007 2.9k citations Guido Kroemer, Lorenzo Galluzzi et al. profile →
  7. Autophagy and the Integrated Stress Response
    2010 2.8k citations Guido Kroemer et al. profile →
  8. Ferroptosis: molecular mechanisms and health implications
    2020 2.8k citations Daolin Tang, Rui Kang et al. profile →
  9. The Pathophysiology of Mitochondrial Cell Death
    2004 2.8k citations Guido Kroemer et al. profile →
  10. Mitochondrial control of cell death
    2000 2.7k citations Guido Kroemer et al. profile →
  11. Immunogenic Cell Death in Cancer Therapy
    2012 2.6k citations Guido Kroemer, Lorenzo Galluzzi et al. profile →
  12. Calreticulin exposure dictates the immunogenicity of cancer cell death
    2006 2.5k citations François Ghiringhelli, Grégoire Mignot et al. profile →
  13. Immunogenic cell death in cancer and infectious disease
    2016 2.2k citations Lorenzo Galluzzi, Oliver Kepp et al. profile →
  14. Molecular mechanisms of cisplatin resistance
    2011 2.2k citations Lorenzo Galluzzi, Laura Senovilla et al. profile →
  15. Biological Functions of Autophagy Genes: A Disease Perspective
    2019 2.1k citations Guido Kroemer et al. profile →
  16. Broadening horizons: the role of ferroptosis in cancer
    2021 2.0k citations Rui Kang, Guido Kroemer et al. profile →
  17. The molecular machinery of regulated cell death
    2019 1.9k citations Daolin Tang, Rui Kang et al. profile →
  18. Molecular mechanisms of necroptosis: an ordered cellular explosion
    2010 1.8k citations Lorenzo Galluzzi, Guido Kroemer et al. profile →
  19. Self-consumption: the interplay of autophagy and apoptosis
    2014 1.8k citations Guido Kroemer et al. profile →
  20. Tumor Cell Metabolism: Cancer's Achilles' Heel
    2008 1.8k citations Guido Kroemer et al. profile →
  21. THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS
    1998 1.7k citations Guido Kroemer et al. profile →
  22. Autophagy and Aging
    2011 1.7k citations Guido Kroemer et al. profile →
  23. The proto-oncogene Bcl-2 and its role in regulating apoptosis
    1997 1.6k citations Guido Kroemer profile →
  24. The immune contexture in cancer prognosis and treatment
    2017 1.6k citations Laurence Zitvogel, Guido Kroemer et al. profile →
  25. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.
    1995 1.4k citations Guido Kroemer et al. The Journal of Experimental Medicine profile →
  26. Targeting mitochondria for cancer therapy
    2010 1.4k citations Lorenzo Galluzzi, Guido Kroemer et al. profile →
  27. Inhibition of Macroautophagy Triggers Apoptosis
    2005 1.4k citations Philippe Dessen, Gérard Pierron et al. profile →
  28. Immunological aspects of cancer chemotherapy
    2007 1.3k citations Laurence Zitvogel, François Ghiringhelli et al. profile →
  29. Macrophages and Metabolism in the Tumor Microenvironment
    2019 1.3k citations Ilio Vitale, Guido Kroemer et al. profile →
  30. Mitochondrial control of apoptosis
    1997 1.3k citations Guido Kroemer et al. profile →
  31. Organelle-specific initiation of cell death pathways
    2001 1.2k citations Guido Kroemer et al. profile →
  32. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
    2005 1.2k citations François Ghiringhelli, S. Roux et al. The Journal of Experimental Medicine profile →
  33. Autophagic cell death: the story of a misnomer
    2008 1.2k citations Guido Kroemer et al. profile →
  34. Mitochondrial control of nuclear apoptosis.
    1996 1.2k citations Guido Kroemer et al. The Journal of Experimental Medicine profile →
  35. Lysosomal membrane permeabilization in cell death
    2008 1.2k citations Guido Kroemer et al. profile →
  36. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
    2015 1.1k citations Lorenzo Galluzzi, Oliver Kepp et al. profile →
  37. Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
    2011 1.1k citations Isabelle Martins, Yuting Ma et al. profile →
  38. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death
    2001 1.1k citations Guido Kroemer et al. profile →
  39. Lysosomes and autophagy in cell death control
    2005 1.1k citations Guido Kroemer et al. profile →
  40. Mechanisms of cytochrome c release from mitochondria
    2006 1.1k citations Carmen Garrido, Lorenzo Galluzzi et al. profile →
  41. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.
    1995 1.0k citations Guido Kroemer et al. The Journal of Experimental Medicine profile →
  42. Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis
    1998 1.0k citations Catherine Brenner, Guido Kroemer et al. profile →
  43. Acetyl Coenzyme A: A Central Metabolite and Second Messenger
    2015 995 citations Federico Pietrocola, Lorenzo Galluzzi et al. profile →
  44. Cancer despite immunosurveillance: immunoselection and immunosubversion
    2006 986 citations Laurence Zitvogel, Guido Kroemer et al. profile →
  45. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
    2016 976 citations Jonathan M. Pitt, Aurélien Marabelle et al. profile →
  46. Cell death by mitotic catastrophe: a molecular definition
    2004 973 citations Guido Kroemer et al. profile →
  47. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.
    1996 964 citations Guido Kroemer et al. The Journal of Experimental Medicine profile →
  48. Type I interferons in anticancer immunity
    2015 964 citations Laurence Zitvogel, Lorenzo Galluzzi et al. profile →
  49. Mitochondrial metabolism and cancer
    2017 953 citations Guido Kroemer, Lorenzo Galluzzi et al. profile →
  50. Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging
    2011 949 citations Lorenzo Galluzzi, Guido Kroemer et al. profile →
  51. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
    2020 932 citations Lorenzo Galluzzi, Laurence Zitvogel et al. profile →
  52. Immunogenic cell stress and death
    2022 919 citations Guido Kroemer, Laurence Zitvogel et al. profile →
  53. Immunogenic death of colon cancer cells treated with oxaliplatin
    2009 917 citations Oliver Kepp, Isabelle Martins et al. profile →
  54. Immunogenic and tolerogenic cell death
    2009 916 citations Laurence Zitvogel, Guido Kroemer et al. profile →
  55. Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1
    2007 912 citations Maria Chiara Maiuri, Alfredo Criollo et al. profile →
  56. Cytoplasmic functions of the tumour suppressor p53
    2009 874 citations Guido Kroemer et al. profile →
  57. The biochemistry of programmed cell death
    1995 860 citations Guido Kroemer et al. profile →
  58. The mitochondrion in apoptosis: how Pandora's box opens
    2001 842 citations Guido Kroemer et al. profile →
  59. Ferroptosis is a type of autophagy-dependent cell death
    2019 837 citations Rui Kang, Guido Kroemer et al. profile →
  60. Hsp27 negatively regulates cell death by interacting with cytochrome c
    2000 814 citations Guido Kroemer, Éric Solary et al. profile →
  61. Decoding cell death signals in liver inflammation
    2013 801 citations Catherine Brenner, Lorenzo Galluzzi et al. profile →
  62. Autophagy in healthy aging and disease
    2021 798 citations Guido Kroemer et al. profile →
  63. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
    2016 790 citations Jonathan M. Pitt, Romain Daillère et al. profile →
  64. Current development of mTOR inhibitors as anticancer agents
    2006 778 citations Guido Kroemer et al. profile →
  65. Detection of immunogenic cell death and its relevance for cancer therapy
    2020 756 citations Oliver Kepp, Guido Kroemer et al. profile →
  66. Mitochondrial permeability transition is a central coordinating event of apoptosis.
    1996 753 citations Guido Kroemer et al. The Journal of Experimental Medicine profile →
  67. Spermidine in health and disease
    2018 747 citations Frank Madeo, Federico Pietrocola et al. profile →
  68. Cell death by necrosis: towards a molecular definition
    2006 745 citations Guido Kroemer et al. profile →
  69. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
    2017 737 citations Xinxin Song, Rui Kang et al. profile →
  70. Mitochondria as regulators of apoptosis: doubt no more
    1998 722 citations Guido Kroemer et al. profile →
  71. Heat-shock protein 70 antagonizes apoptosis-inducing factor
    2001 714 citations Carmen Garrido, Guido Kroemer et al. profile →
  72. Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
    2009 688 citations Oliver Kepp, Gérard Pierron et al. profile →
  73. Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
    2013 681 citations Laurence Zitvogel, Lorenzo Galluzzi et al. profile →
  74. Bcl-2 family members: Dual regulators of apoptosis and autophagy
    2008 674 citations Guido Kroemer et al. profile →
  75. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
    2017 672 citations Lorenzo Galluzzi, Guido Kroemer et al. profile →
  76. Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis
    2000 672 citations Guido Kroemer et al. profile →
  77. The central executioners of apoptosis: caspases or mitochondria?
    1998 663 citations Guido Kroemer et al. profile →
  78. Metabolic Control of Autophagy
    2014 662 citations Lorenzo Galluzzi, Federico Pietrocola et al. profile →
  79. Autophagy and Mitophagy in Cardiovascular Disease
    2017 646 citations Guido Kroemer, Lorenzo Galluzzi et al. profile →
  80. Systems biology of cisplatin resistance: past, present and future
    2014 646 citations Lorenzo Galluzzi, Ilio Vitale et al. profile →
  81. Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation
    2005 588 citations François Ghiringhelli, S. Roux et al. The Journal of Experimental Medicine profile →
  82. The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related Proteins
    1998 574 citations Catherine Brenner, Guido Kroemer et al. The Journal of Experimental Medicine profile →
  83. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis
    2007 502 citations Aurélien Deniaud, Ossama Sharaf El Dein et al. profile →

Peers

Guido Kroemer
Comparison fields: 5 of 213
  • Molecular Biology 128.2k
  • Immunology 51.4k
  • Epidemiology 47.5k
  • Oncology 45.9k
  • Cancer Research 28.9k
Replace Michael Karin with:
Michael Karin United States
Craig B. Thompson United States
Robert A. Weinberg United States
Shizuo Akira Japan
Richard A. Flavell United States
Lewis C. Cantley United States
Kenneth J. Livak United States
Bert Vogelstein United States
Matthias Mann Germany
Alberto Mantovani Italy
Michael Karin United States View profile →
Citations per field, relative to Guido Kroemer
Guido Kroemer · 1×
Citations per year, relative to Guido Kroemer
Guido Kroemer · 1×

Countries citing papers authored by Guido Kroemer

Since Specialization
Citations

This map shows the geographic impact of Guido Kroemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Kroemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Kroemer more than expected).

Fields of papers citing papers by Guido Kroemer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Kroemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Kroemer. The network helps show where Guido Kroemer may publish in the future.

Co-authorship network of co-authors of Guido Kroemer

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Kroemer. A scholar is included among the top collaborators of Guido Kroemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Kroemer. Guido Kroemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet
2024 ·Methods in molecular biology ·Omar Motiño, Sijing Li, Flavia Lambertucci, Gerasimos Anagnostopoulos, Léa Montégut, Uxía Nogueira-Recalde, (unknown), Maria Chiara Maiuri, Guido Kroemer, Isabelle Martins
2
2
Immunogenic cell death in cancer: concept and therapeutic implications breakdown →
2023 ·Journal of Translational Medicine ·Lorenzo Galluzzi, Oliver Kepp, Erik C. Hett, Guido Kroemer, Francesco M. Marincola
94
3
Acyl coenzyme A binding protein (ACBP): An aging‐ and disease‐relevant “autophagy checkpoint”
2023 ·Aging Cell ·Léa Montégut, Mahmoud Abdellatif, Omar Motiño, Frank Madeo, Isabelle Martins, Vı́ctor Quesada, Carlos López-Otı́n, Guido Kroemer
23
4
HSP90 Mediates IFNγ-Induced Adaptive Resistance to Anti-PD-1 Immunotherapy
2022 ·Cancer Research ·Ke Liu, Jun Huang, Jiao Liu, Changfeng Li, Guido Kroemer, Daolin Tang, Rui Kang
26
5
Science-Driven Nutritional Interventions for the Prevention and Treatment of Cancer
2022 ·Cancer Discovery ·Léa Montégut, Rafael de Cabo, Laurence Zitvogel, Guido Kroemer
26
6
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
2021 ·Cancer Discovery ·Lisa Derosa, Bertrand Routy, Antoine Desîlets, Romain Daillère, Safae Terrisse, Guido Kroemer, Laurence Zitvogel
100
7
Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers
2020 ·Cancer Discovery ·Xinxin Song, Zhuan Zhou, Hongchun Li, Yifan Xue, Xinghua Lu, İvet Bahar, Oliver Kepp, Mien‐Chie Hung, Guido Kroemer, Yong Wan
101
8
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy
2017 ·Cancer Research ·Laetitia Fend, Takahiro Yamazaki, (unknown), (unknown), Murielle Gantzer, (unknown), Xavier Préville, Éric Quéméneur, Oliver Kepp, Julien Adam, Aurélien Marabelle, Jonathan M. Pitt, Guido Kroemer, Laurence Zitvogel
108
9
STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells
2015 ·Cancer Research ·Heng Yang, Takahiro Yamazaki, Federico Pietrocola, Heng Zhou, Laurence Zitvogel, Yuting Ma, Guido Kroemer
77
10
Expression of P2X7 Receptor Increases In Vivo Tumor Growth
2012 ·Cancer Research ·Elena Adinolfi, Lizzia Raffaghello, Anna Lisa Giuliani, Luigi Cavazzini, Marina Capece, Paola Chiozzi, Giovanna Bianchi, Guido Kroemer, Vito Pistoia, Francesco Di Virgilio
302
11
Peptides and Aptamers Targeting HSP70: A Novel Approach for Anticancer Chemotherapy
2011 ·Cancer Research ·Anne-Laure Rérole, Jessica Gobbo, Aurélie de Thonel, E. Schmitt, Jean-Paul Paı̈s de Barros, Arlette Hammann, David Lanneau, Eric Fourmaux, (unknown), Olivier Micheau, Laurent Lagrost, Pierre Colas, Guido Kroemer, Carmen Garrido
124
12
IL-18 Induces PD-1–Dependent Immunosuppression in Cancer
2011 ·Cancer Research ·Magali Terme, Evelyn Ullrich, Laetitia Aymeric, Kathrin Meinhardt, Mélanie Desbois, Nicolas Delahaye, Sophie Viaud, Bernard Ryffel, Hideo Yagita∥, Gilles Kaplanski, Armelle Prévost‐Blondel, Masashi Kato, Joachim L. Schultze, Éric Tartour, Guido Kroemer, Nathalie Chaput, Laurence Zitvogel
286
13
Integration of Host-Related Signatures with Cancer Cell–Derived Predictors for the Optimal Management of Anticancer Chemotherapy
2010 ·Cancer Research ·Laurence Zitvogel, Oliver Kepp, Laetitia Aymeric, Yuting Ma, Clara Locher, Nicolas F. Delahaye, Fabrice André, Guido Kroemer
23
14
miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
2010 ·Cancer Research ·Lorenzo Galluzzi, Eugenia Morselli, Ilio Vitale, Oliver Kepp, Laura Senovilla, Alfredo Criollo, Nicolas Servant, Caroline Paccard, Philippe Hupé, Thomas Robert, Hugues Ripoche, Vladimir Lazar, Annick Harel‐Bellan, Philippe Dessen, Emmanuel Barillot, Guido Kroemer
239
15
Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands
2010 ·Cancer Research ·Rosa Conforti, Yuting Ma, Yannis Morel, Carine Paturel, Magali Terme, Sophie Viaud, Bernard Ryffel, Maria Ferrantini, Ravindra Uppaluri, Robert D. Schreiber, Christophe Combadière, Nathalie Chaput, Fabrice André, Guido Kroemer, Laurence Zitvogel
87
16
The Dendritic Cell–like Functions of IFN-Producing Killer Dendritic Cells Reside in the CD11b+ Subset and Are Licensed by Tumor Cells
2009 ·Cancer Research ·Magali Terme, Grégoire Mignot, Evelyn Ullrich, Mathieu Bonmort, Véronique Minard-Colin, Alexandra Jacquet, Joachim L. Schultze, Guido Kroemer, Claude Leclerc, Nathalie Chaput, Laurence Zitvogel
23
17
A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib
2007 ·Cancer Research ·Thibault De La Motte Rouge, Lorenzo Galluzzi, Ken A. Olaussen, Yaël Zermati, Ezgi Tasdemir, Thomas Robert, Hugues Ripoche, Vladimir Lazar, Philippe Dessen, Francis Harper, Gérard Pierron, Guillaume Pinna, Natália de Souza Araujo, (unknown), Jean‐Pierre Armand, Tai W. Wong, Jean Charles Soria, Guido Kroemer
109
18
Chemosensitization by Knockdown of Adenine Nucleotide Translocase-2
2006 ·Cancer Research ·Morgane Le Bras, Annie Borgne‐Sanchez, Zahia Touat, Ossama Sharaf El Dein, Aurélien Deniaud, Evelyne Maillier, Gaël Lecellier, Dominique Rebouillat, Christophe Lemaire, Guido Kroemer, (unknown), Catherine Brenner
80
19
Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation breakdown →
2005 ·The Journal of Experimental Medicine ·François Ghiringhelli, (unknown), S. Roux, Arnaud Parcellier, E. Schmitt, Éric Solary, Guido Kroemer, François Martin, Bruno Chauffert, Laurence Zitvogel
588
20
Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance
2005 ·Journal of Clinical Investigation ·Helen M. Marriott, Colin D. Bingle, Robert C. Read, (unknown), Guido Kroemer, Paul G. Hellewell, Ruth W. Craig, Moira K. B. Whyte, David H. Dockrell
80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Karin Breakdown of academic impact, for papers by Craig B. Thompson Breakdown of academic impact, for papers by Robert A. Weinberg Breakdown of academic impact, for papers by Shizuo Akira Breakdown of academic impact, for papers by Richard A. Flavell Breakdown of academic impact, for papers by Lewis C. Cantley Breakdown of academic impact, for papers by Kenneth J. Livak Breakdown of academic impact, for papers by Bert Vogelstein Breakdown of academic impact, for papers by Matthias Mann Breakdown of academic impact, for papers by Alberto Mantovani
Rankless by CCL
2026